Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Did you know there is a new drug for Amyloidosis being reviewed by FDA and anticipated to be approved ? LEQEMBI . Another, - being reviewed

A MyAmyloidosisTeam Member asked a question 💭
Loxahatchee, FL
July 13, 2024
 · 
Be the first to react
A MyAmyloidosisTeam Member

Well Louis if I had to take a guess… it works on the amyloid which causes Alzheimer’s. That’s not the same amyloid as we have, it works with the central nervous system. I have AL and my problem is the peripheral nervous system. There’s a drug whose clinical trials ends March 2025. It’s supposed to remove the existing amyloid. Fingers crossed it works! It would be a game changer if it did 🤞

July 13, 2024
A MyAmyloidosisTeam Member

No I don’t think so. It’s more for Alzheimer’s patients

July 13, 2024
A MyAmyloidosisTeam Member

Is the drug you ,mentioned intended to be used for AL patients.

July 13, 2024

Related Questions

View All

Any information on depleter drug trials for amyloidosis wild type

A MyAmyloidosisTeam Member asked a question 💭

Are these reputable news sources, Principia Scientific International, Public Health Policy Journel, Global Research, Research Gate ?

A MyAmyloidosisTeam Member asked a question 💭

Recently read that 100% of Covid vaccinated had amyloid micro clots. Could this have precipitated amylodosis?

A MyAmyloidosisTeam Member asked a question 💭

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In